Abstract
The authors report the case of a severely retarded, 19-year-old female (treated with primidone 250 mg tid since age 12) who was admitted with visual and auditory hallucinations. After four days of continuing hallucinations, she went into classic catatonic schizophrenia. Upon examination, her primidone serum level was found to be well above the normal therapeutic range. The primidone dosage was decreased, and symptoms subsided as serum levels returned to normal.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 551-552 |
| Number of pages | 2 |
| Journal | Drug Intelligence and Clinical Pharmacy |
| Volume | 17 |
| Issue number | 7-8 |
| State | Published - Jan 1 1983 |
| Externally published | Yes |
Fingerprint
All Science Journal Classification (ASJC) codes
- Pharmacology, Toxicology and Pharmaceutics(all)
- Pharmacology (medical)
Cite this
Primidone-induced catatonic schizophrenia. / Sher, A.; Andersen, J. M.; Bhatia, Subhash.
In: Drug Intelligence and Clinical Pharmacy, Vol. 17, No. 7-8, 01.01.1983, p. 551-552.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Primidone-induced catatonic schizophrenia
AU - Sher, A.
AU - Andersen, J. M.
AU - Bhatia, Subhash
PY - 1983/1/1
Y1 - 1983/1/1
N2 - The authors report the case of a severely retarded, 19-year-old female (treated with primidone 250 mg tid since age 12) who was admitted with visual and auditory hallucinations. After four days of continuing hallucinations, she went into classic catatonic schizophrenia. Upon examination, her primidone serum level was found to be well above the normal therapeutic range. The primidone dosage was decreased, and symptoms subsided as serum levels returned to normal.
AB - The authors report the case of a severely retarded, 19-year-old female (treated with primidone 250 mg tid since age 12) who was admitted with visual and auditory hallucinations. After four days of continuing hallucinations, she went into classic catatonic schizophrenia. Upon examination, her primidone serum level was found to be well above the normal therapeutic range. The primidone dosage was decreased, and symptoms subsided as serum levels returned to normal.
UR - http://www.scopus.com/inward/record.url?scp=0020565692&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0020565692&partnerID=8YFLogxK
M3 - Article
VL - 17
SP - 551
EP - 552
JO - Annals of Pharmacotherapy
JF - Annals of Pharmacotherapy
SN - 1060-0280
IS - 7-8
ER -